Odintsova, S. V., Sviridenko, M. A., Cheremnykh, A. O., Filippova, E. A., Urtenova, M. A., & Orlov, S. V. (2020). Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma. IP Habib O.N.
Style de citation Chicago (17e éd.)Odintsova, Svetlana V., Mariia A. Sviridenko, Antonina O. Cheremnykh, Elena A. Filippova, Magaripa A. Urtenova, et Sergei V. Orlov. Clinical Case of Long-term Use of Osimertinib in the Treatment of EGFR Mutation-positive Lung Adenocarcinoma. IP Habib O.N, 2020.
Style de citation MLA (8e éd.)Odintsova, Svetlana V., et al. Clinical Case of Long-term Use of Osimertinib in the Treatment of EGFR Mutation-positive Lung Adenocarcinoma. IP Habib O.N, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.